Wealth Advisors of Tampa Bay’s AbbVie ABBV Stock Holding History

Wealth Advisors of Tampa Bay’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$206K	Hold	945	–	–	0.07%	90
2025 Q4	$216K	Hold	945	–	–	0.07%	86
2025 Q3	$219K	Buy	+945	New	+$192K	0.07%	88
2025 Q2	–	Sell	-860	Closed	-$180K	–	91
2025 Q1	$180K	Buy	+860	New	+$167K	0.07%	89
2018 Q2	–	Sell	-44,791	Closed	-$4.24M	–	70
2018 Q1	$4.24M	Sell	44,791 -2,905	-6%	-$319K	3.07%	7
2017 Q4	$4.74M	Buy	+47,696	New	+$4.5M	3.25%	3

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wealth Advisors of Tampa Bay's ABBV Position: Q1 2026 in Review

Wealth Advisors of Tampa Bay held its AbbVie (ABBV) position steady in Q1 2026 at 945 shares worth $206K. The position accounts for 0.07% of the portfolio, ranked #90.

Wealth Advisors of Tampa Bay first reported a position in ABBV in Q4 2017 and has held it in 6 quarters since. The position peaked at $4.74M in Q4 2017. 4,087 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Wealth Advisors of Tampa Bay held 945 shares of AbbVie worth $206K as of Q1 2026.
Wealth Advisors of Tampa Bay left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.07% of Wealth Advisors of Tampa Bay's portfolio in Q1 2026, its #90 holding.
Wealth Advisors of Tampa Bay first reported a position in AbbVie in Q4 2017 and has held it in 6 quarters since.
Wealth Advisors of Tampa Bay's AbbVie position peaked at $4.74M in Q4 2017.
4,087 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Wealth Advisors of Tampa Bay's 13F filing for Q1 2026, filed 14 May 2026.